DT
Dravite Therapeutics, Inc.
SEC filingOther · San Francisco, CA
Amount raised$53Msold at filing
Total offering$53M
Investors in the raise11count reported to the SEC
FiledSep 3, 2026first sale Aug 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
RISHI GUPTADirector
MATTHEW MOOREExecutive Officer, Director
JOSEPH SUMExecutive Officer, Director
BARBARA KOSACZDirector
SANDEEP KULKARNIDirector
JEREMY GOLDBERGDirector
Executive officers, directors and promoters as listed on the Form D.